Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • Our Impact
    • Why CIFAR?
    • Impact Clusters
    • News
    • CIFAR Strategy
    • Nurturing a Resilient Earth
    • AI Impact
    • Donor Impact
    • CIFAR 40
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
    • Staff Directory
  • Support Us
  • About
    • Our Story
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
    • Statement on Institutional Neutrality
    • Research Security
  • fr
  • Home
  • Bio

Follow Us

Lorraine Lipscombe

Lorraine Lipscombe

Appointment

Solution Network Member

AI for Diabetes Prediction & Prevention

Pan-Canadian AI Strategy

Connect

Google Scholar

About

Lipscombe leads a research program in diabetes epidemiology and health services with a focus in two areas: the relationship between diabetes and cancer, and identifying and preventing risk of diabetes after gestational diabetes (GDM). Her overall goal is to identify and target modifiable risk factors and gaps in health care for persons affected by diabetes. Lipscombe has expertise in healthcare administrative database research, cohort studies and pragmatic clinical trials. Her earlier research showed a higher cancer risk, prevalence and stage, and lower cancer screening in diabetes patients. She then developed and trialed a post-GDM diabetes prevention program, and is now conducting a series of studies to quantify risk of diabetes after GDM. Lipscombe is the inaugural director for the University of Toronto’s Novo Nordisk Network for Healthy Populations, a research network that aims to reduce inequities in diabetes burden through better care, lower risk factors, and healthier living environments.

Awards

  • The Janet Rossant Lectureship, University of Toronto (2022)
  • Diabetes Investigator Award, Diabetes Canada (2018)
  • The William Goldie Prize and Travel Award in Research, University of Toronto (2015)
  • CIHR New Investigator Award, Canadian Institutes of Health Research (2012)
  • Clinician Scientist Award, Diabetes Canada (2007)

Relevant Publications

  • Ho, J. S. S., Read, S. H., Giannakeas, V., Sarma, S., Berger, H., Feig, D. S., Fleming, K., Ray, J. G., Rosella, L., Shah, B. R., & Lipscombe, L. L. (2023). The association between immigration status and the development of type 2 diabetes in women with a prior diagnosis of gestational diabetes: A population-based study. Diabetic medicine : a journal of the British Diabetic Association, e15128. Advance online publication.
  • Read, S. H., Rosella, L. C., Berger, H., Feig, D. S., Fleming, K., Ray, J. G., Shah, B. R., & Lipscombe, L. L. (2021). BMI and risk of gestational diabetes among women of South Asian and Chinese ethnicity: a population-based study. Diabetologia, 64(4), 805–813.
  • Lipscombe, L. L., Hwee, J., Webster, L., Shah, B. R., Booth, G. L., & Tu, K. (2018). Identifying diabetes cases from administrative data: a population-based validation study. BMC health services research, 18(1), 316.
  • Lipscombe, L. L., Fischer, H. D., Austin, P. C., Fu, L., Jaakkimainen, R. L., Ginsburg, O., Rochon, P. A., Narod, S., & Paszat, L. (2015). The association between diabetes and breast cancer stage at diagnosis: a population-based study. Breast cancer research and treatment, 150(3), 613–620.
  • Lipscombe, L. L., & Hux, J. E. (2007). Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet (London, England), 369(9563), 750–756.

Institution

University of Toronto

Women's College Hospital

Education

  • Certificate, Endocrinology and Metabolism, Royal College of Physicians and Surgeons of Canada
  • Certificate, Internal Medicine, Royal College of Physicians and Surgeons of Canada
  • MSc (Clinical Epidemiology), Institute of Health Policy, Management and Evaluation, University of Toronto
  • MDCM, Faculty of Medicine, McGill University
  • BSc (Psychology), Concordia University

Country

Canada

Support Us

The Canadian Institute for Advanced Research (CIFAR) is a globally influential research organization proudly based in Canada. We mobilize the world’s most brilliant people across disciplines and at all career stages to advance transformative knowledge and solve humanity’s biggest problems, together. We are supported by the governments of Canada, Alberta and Québec, as well as Canadian and international foundations, individuals, corporations and partner organizations.

Donate Now
CIFAR footer logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2025 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

Fields marked with an * are required

Je préfère m’inscrire en français (cliquez ici).


Subscribe to our CIFAR newsletters: *

You can unsubscribe from these communications at any time. View our privacy policy.


As a subscriber you will also receive a digital copy of REACH, our annual magazine which highlights our researchers and their breakthroughs with long-form features, interviews and illustrations.


Please provide additional information if you would like to receive a print edition of REACH.


This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more

Notifications